China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2005 | 06-2004 | 06-2003 | 06-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,842 | -504 | -521 | -1,104 | N/A |
| Depreciation Amortization | N/A | N/A | 67 | 83 | N/A |
| Accounts receivable | N/A | N/A | 1 | -3 | N/A |
| Accounts payable and accrued liabilities | -68 | 71 | 39 | 22 | N/A |
| Other Working Capital | -68 | 71 | 39 | 33 | N/A |
| Other Operating Activity | 1,779 | 328 | 282 | 669 | 0 |
| Operating Cash Flow | $-200 | $-36 | $-93 | $-299 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 33 | N/A | N/A |
| Net Acquisitions | N/A | 3 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -250 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -250 | 0 |
| Investing Cash Flow | $N/A | $3 | $33 | $-250 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 35 | 22 | 287 | N/A |
| Debt Repayment | N/A | N/A | N/A | -5 | N/A |
| Common Stock Issued | 200 | N/A | 39 | 256 | N/A |
| Other Financing Activity | 0 | -4 | 0 | 0 | 0 |
| Financing Cash Flow | $200 | $32 | $61 | $538 | $N/A |
| Beginning Cash Position | 0 | 2 | 1 | 13 | N/A |
| End Cash Position | N/A | 0 | 2 | 1 | N/A |
| Net Cash Flow | $0 | $-2 | $1 | $-11 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -200 | -36 | -93 | -299 | N/A |
| Free Cash Flow | -200 | -36 | -93 | -299 | 0 |